Recent Quarter Total Invested
$1.90 B
Recent Quarter Institutional Ownership Percentage
87.32%
Total Invested of Last Quarter
$3.20 B
Ownership Percentage of Last Quarter
84.42%
Iovance Biotherapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 08/13/2024 | 25.95 M | $208.12 M | 4.16% | 9.75% |
| PERCEPTIVE ADVISORS LLC | 08/16/2024 | 25.93 M | $207.98 M | 34.56% | 9.74% |
| MHR FUND MANAGEMENT LLC | 08/14/2024 | 24.00 M | $192.46 M | 0.00% | 9.01% |
| BLACKROCK INC. | 08/13/2024 | 21.23 M | $170.23 M | 6.50% | 7.97% |
| STATE STREET CORP | 08/14/2024 | 12.63 M | $101.25 M | 21.36% | 4.74% |
| AVORO CAPITAL ADVISORS LLC | 08/14/2024 | 11.70 M | $93.83 M | 0.00% | 4.39% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 08/14/2024 | 7.55 M | $60.53 M | 115.35% | 2.84% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/09/2024 | 5.79 M | $46.42 M | 5.08% | 2.17% |
| ARTISAN PARTNERS LIMITED PARTNERSHIP | 08/12/2024 | 5.11 M | $40.99 M | -0.52% | 1.92% |
| BALYASNY ASSET MANAGEMENT L.P. | 08/14/2024 | 4.54 M | $36.42 M | 278.11% | 1.71% |
| LONG FOCUS CAPITAL MANAGEMENT, LLC | 08/14/2024 | 4.13 M | $33.14 M | 195.08% | 1.55% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 08/14/2024 | 3.48 M | $27.93 M | -33.89% | 1.31% |
| JPMORGAN CHASE & CO | 08/12/2024 | 3.44 M | $27.57 M | -21.60% | 1.29% |
| MORGAN STANLEY | 08/14/2024 | 2.82 M | $22.64 M | 4.90% | 1.06% |
| HOOD RIVER CAPITAL MANAGEMENT LLC | 08/14/2024 | 2.73 M | $21.91 M | 4.12% | 1.03% |
| GOLDMAN SACHS GROUP INC | 08/13/2024 | 2.62 M | $21.03 M | -30.69% | 0.98% |
| PRINCIPAL FINANCIAL GROUP INC | 07/29/2024 | 2.54 M | $20.34 M | 26.44% | 0.95% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 08/14/2024 | 2.49 M | $19.98 M | -28.69% | 0.94% |
| BIOIMPACT CAPITAL LLC | 08/14/2024 | 2.37 M | $18.98 M | 7.58% | 0.89% |
| DIMENSIONAL FUND ADVISORS LP | 08/09/2024 | 2.27 M | $18.17 M | -21.10% | 0.85% |
| BANK OF AMERICA CORP /DE/ | 08/14/2024 | 2.17 M | $17.38 M | 41.44% | 0.81% |
| NORTHERN TRUST CORP | 08/14/2024 | 2.17 M | $17.38 M | -2.71% | 0.81% |
| PALO ALTO INVESTORS LP | 08/14/2024 | 2.12 M | $16.97 M | 0.17% | 0.80% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 08/14/2024 | 2.05 M | $16.45 M | 56.13% | 0.77% |
| UBS ASSET MANAGEMENT AMERICAS INC | 08/14/2024 | 1.99 M | $16.00 M | 1,008.98% | 0.75% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/12/2024 | 1.98 M | $15.92 M | 3.76% | 0.75% |
| EAGLE ASSET MANAGEMENT INC | 08/12/2024 | 1.94 M | $15.62 M | 251.66% | 0.73% |
| RICE HALL JAMES & ASSOCIATES, LLC | 08/07/2024 | 1.64 M | $13.12 M | -4.54% | 0.61% |
| MARSHALL WACE, LLP | 08/14/2024 | 1.61 M | $12.93 M | 100.00% | 0.61% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 08/14/2024 | 1.56 M | $12.47 M | -47.56% | 0.58% |
| 683 CAPITAL MANAGEMENT, LLC | 08/14/2024 | 1.50 M | $12.03 M | 22.45% | 0.56% |
| BRAIDWELL LP | 08/14/2024 | 1.47 M | $11.76 M | 122.21% | 0.55% |
| NUVEEN ASSET MANAGEMENT, LLC | 08/09/2024 | 1.33 M | $10.65 M | -19.74% | 0.50% |
| C WORLDWIDE GROUP HOLDING A/S | 07/31/2024 | 1.26 M | $10.11 M | 18.87% | 0.47% |
| NEW YORK STATE COMMON RETIREMENT FUND | 07/31/2024 | 1.21 M | $9.70 M | 3.79% | 0.45% |
| BANK OF NEW YORK MELLON CORP | 07/25/2024 | 1.03 M | $8.30 M | 24.04% | 0.39% |
| JANE STREET GROUP, LLC | 08/15/2024 | 1.03 M | $8.26 M | 0.91% | 0.39% |
| ARTAL GROUP S.A. | 08/14/2024 | 1.01 M | $8.11 M | 100.00% | 0.38% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/15/2024 | 991,649 | $7.95 M | -45.42% | 0.37% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/15/2024 | 989,200 | $7.93 M | 28.58% | 0.37% |
| NORGES BANK | 08/14/2024 | 942,983 | $7.56 M | 100.00% | 0.35% |
| PICTET ASSET MANAGEMENT HOLDING SA | 08/13/2024 | 920,077 | $7.38 M | -71.69% | 0.35% |
| RHENMAN & PARTNERS ASSET MANAGEMENT AB | 08/13/2024 | 920,000 | $7.38 M | -3.66% | 0.35% |
| OPALEYE MANAGEMENT INC. | 08/14/2024 | 897,000 | $7.19 M | 0.00% | 0.34% |
| UBS GROUP AG | 08/14/2024 | 795,204 | $6.38 M | 15.10% | 0.30% |
| ORION INVESTMENT CO | 08/15/2024 | 794,700 | $6.37 M | 100.00% | 0.30% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2024 | 774,783 | $6.21 M | 100.00% | 0.29% |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 08/12/2024 | 769,160 | $6.17 M | 132.53% | 0.29% |
| BOXER CAPITAL, LLC | 08/14/2024 | 750,000 | $6.02 M | 0.00% | 0.28% |
| GROUP ONE TRADING, L.P. | 08/14/2024 | 731,607 | $5.87 M | 49.91% | 0.27% |
Iovance Biotherapeutics, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of IOVA shares?
During the previous two years, 381 institutional investors and hedge funds held shares of Iovance Biotherapeutics, Inc.. The most heavily invested institutionals were:
VANGUARD GROUP INC: 25.95 M
PERCEPTIVE ADVISORS LLC: 25.93 M
MHR FUND MANAGEMENT LLC: 24 M
BlackRock Inc.: 21.23 M
STATE STREET CORP: 12.63 M
Avoro Capital Advisors LLC: 11.7 M
-
What percentage of Iovance Biotherapeutics, Inc. stock is owned by institutional investors?
87.32% of Iovance Biotherapeutics, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at IOVA ?
Institutional investors have bought a total of 241.91 M shares in the last 24 months. This purchase volume represents approximately $2.53 B in transactions.